Loading clinical trials...
Loading clinical trials...
AZD9291 Early Access Program (EAP) was available in Taiwan during October 2015 to September 2016, a time period before the approval of AZD9291, to supply the unlicensed AZD9291 for the NSCLC patients ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
NCT05671510 · Non Small Cell Lung Cancer
NCT03340506 · Melanoma, Non Small Cell Lung Cancer, and more
NCT06066138 · Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, and more
NCT07485114 · Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer, and more
NCT05098132 · Advanced Solid Tumor, Non Small Cell Lung Cancer, and more
Research Site
Kaohsiung City
Research Site
Kaohsiung City
Research Site
Taichung
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions